Stuart WH - Search Results

1

Combination therapy for the treatment of multiple sclerosis: challenges and opportunities.

Stuart WH. Stuart WH. Curr Med Res Opin. 2007 Jun;23(6):1199-208. doi: 10.1185/030079907X187838. Epub 2007 Apr 23. Curr Med Res Opin. 2007. PMID: 17559719 Review.

2

Concomitant therapy for multiple sclerosis.

Stuart WH, Vermersch P. Stuart WH, et al. Neurology. 2004 Dec 14;63(11 Suppl 5):S28-34. doi: 10.1212/wnl.63.11_suppl_5.s28. Neurology. 2004. PMID: 15596733 Review.

3

Clinical management of multiple sclerosis: the treatment paradigm and issues of patient management.

Stuart WH. Stuart WH. J Manag Care Pharm. 2004 Jun;10(3 Suppl B):S19-25. J Manag Care Pharm. 2004. PMID: 15253686 Review.

4

Selecting a disease-modifying agent as platform therapy in the long-term management of multiple sclerosis.

Stuart WH, Cohan S, Richert JR, Achiron A. Stuart WH, et al. Neurology. 2004 Dec 14;63(11 Suppl 5):S19-27. doi: 10.1212/wnl.63.11_suppl_5.s19. Neurology. 2004. PMID: 15596732 Review.

5

A randomized blinded trial of combination therapy with cyclophosphamide in patients-with active multiple sclerosis on interferon beta.

Smith DR, Weinstock-Guttman B, Cohen JA, Wei X, Gutmann C, Bakshi R, Olek M, Stone L, Greenberg S, Stuart D, Orav J, Stuart W, Weiner H. Smith DR, et al. Mult Scler. 2005 Oct;11(5):573-82. doi: 10.1191/1352458505ms1210oa. Mult Scler. 2005. PMID: 16193896 Clinical Trial.

6

Randomized study combining interferon and glatiramer acetate in multiple sclerosis.

Lublin FD, Cofield SS, Cutter GR, Conwit R, Narayana PA, Nelson F, Salter AR, Gustafson T, Wolinsky JS; CombiRx Investigators. Lublin FD, et al. Ann Neurol. 2013 Mar;73(3):327-40. doi: 10.1002/ana.23863. Epub 2013 Mar 11. Ann Neurol. 2013. PMID: 23424159 Free PMC article. Clinical Trial.

7

Stepped-care approach to treating MS: a managed care treatment algorithm.

Rich SR, Coleman IC, Cook R, Hum DS, Johnson B, Maves T, Mazanec WJ, Miller JR, Proveaux WJ, Rossman HS, Stuart WH. Rich SR, et al. Among authors: stuart wh. J Manag Care Pharm. 2004 Jun;10(3 Suppl B):S26-32. doi: 10.18553/jmcp.2004.10.S5-A.S26. J Manag Care Pharm. 2004. PMID: 15253687 Free PMC article. Review.

8

Rationale for early treatment with interferon beta-1a in relapsing-remitting multiple sclerosis.

Munschauer FE 3rd, Stuart WH. Munschauer FE 3rd, et al. Among authors: stuart wh. Clin Ther. 1997 Sep-Oct;19(5):868-82. doi: 10.1016/s0149-2918(97)80041-0. Clin Ther. 1997. PMID: 9385476 Review.

9

Efficacy of natalizumab therapy in patients of African descent with relapsing multiple sclerosis: analysis of AFFIRM and SENTINEL data.

Cree BA, Stuart WH, Tornatore CS, Jeffery DR, Pace AL, Cha CH. Cree BA, et al. Among authors: stuart wh. Arch Neurol. 2011 Apr;68(4):464-8. doi: 10.1001/archneurol.2011.45. Arch Neurol. 2011. PMID: 21482925 Clinical Trial.

10

Health-related quality of life in multiple sclerosis: effects of natalizumab.

Rudick RA, Miller D, Hass S, Hutchinson M, Calabresi PA, Confavreux C, Galetta SL, Giovannoni G, Havrdova E, Kappos L, Lublin FD, Miller DH, O'Connor PW, Phillips JT, Polman CH, Radue EW, Stuart WH, Wajgt A, Weinstock-Guttman B, Wynn DR, Lynn F, Panzara MA; AFFIRM and SENTINEL Investigators. Rudick RA, et al. Among authors: stuart wh. Ann Neurol. 2007 Oct;62(4):335-46. doi: 10.1002/ana.21163. Ann Neurol. 2007. PMID: 17696126 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34 results

Search Page